KOPRAN
Back to All Ratios
|
KOPRAN Last 5 Year EBIT Margin History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EBIT Margin(%) | 9.73 | 12.39 | 7.55 | 17.93 | 17.87 |
What is the latest EBIT Margin ratio of KOPRAN ?
Year | EBIT Margin |
---|---|
Mar2025 | 9.73 |
Mar2024 | 12.39 |
Mar2023 | 7.55 |
Mar2022 | 17.93 |
Mar2021 | 17.87 |
How is EBIT Margin of KOPRAN Trending?
Years | EBIT Margin | % Change | |
---|---|---|---|
Mar2025 | 9.73 | -21.47 | |
Mar2024 | 12.39 | 64.11 | |
Mar2023 | 7.55 | -57.89 | |
Mar2022 | 17.93 | 0.34 | |
Mar2021 | 17.87 | - |
Other Financial Ratios of KOPRAN
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Margin ratio of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹803.7 Cr | -2.6% | -5.6% | -43.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,872.0 Cr | 0.6% | 3.6% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,290.0 Cr | 1% | 9.4% | 8% | Stock Analytics | |
CIPLA | ₹132,417.0 Cr | 0.9% | 1.2% | -0.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,125.0 Cr | 1.7% | 1% | 1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,031.0 Cr | -0.5% | -4.2% | -6.3% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | -2.6% |
-5.6% |
-43.8% |
SENSEX | 1.8% |
1.9% |
2.4% |
You may also like the below Video Courses